Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
22.08. | PVA TePla - Strong Q224 results | 1.161 | PVA TePla's (PVA's) Q224 results were strong and management reiterated its FY24 guidance and FY25 outlook of moderate growth, despite a weak order intake. The outlook is based on the expectation of... ► Artikel lesen | ||
22.08. | Nano Dimension - Creating a leader in additive manufacturing | 322 | Nano Dimension reported record revenue of $15.0m in Q224, slightly higher year-on-year and 12% higher quarter-on-quarter. The Reshaping Nano initiative continued to reduce cash burn, which was down... ► Artikel lesen | ||
21.08. | Singapore Post - Q1 profits more than double | 274 | The Q125 results shine a light on the latest initiatives to underpin the inherent value within Singapore Post, which include a review of the Australian operations and ongoing discussions with the Singapore... ► Artikel lesen | ||
21.08. | Information Services Corporation - Cash flow fuelling ambitious growth plan | 253 | Information Services Corporation (ISC) has entered a new era of strategic growth, striving to double both revenue and adjusted EBITDA (on an FY23 basis) by 2028. Its Registry Operations will be a strong... ► Artikel lesen | ||
21.08. | AAC Clyde Space - Volatility affecting progress | 278 | AAC Clyde Space offers exposure to the fast-growing low Earth orbit space market. The difficulties experienced in Q2, affecting full year expectations, are clearly disappointing if not wholly unexpected... ► Artikel lesen | ||
20.08. | Foxtons Group - Valuation offers 100% upside | 260 | Foxtons Group's H1 results clearly highlight the success of the strategy the company embarked on at the start of last year. Although there is still work to be done, significant progress has been made... ► Artikel lesen | ||
20.08. | ProCredit Holding - Executing its updated strategy | 653 | ProCredit Holding (PCB) recorded strong sequential loan book growth of 3.8% in Q224 (and 6.9% in H124), a run-rate ahead of management's FY24 guidance of 10% (excluding FX). This was achieved at a stable... ► Artikel lesen | ||
20.08. | The Biotech Growth Trust - Valuations starting to improve with more to come | 188 | The Biotech Growth Trust (BIOG) has two experienced managers, Geoff Hsu and Josh Golomb, at leading global healthcare specialist OrbiMed. They remain very positive on the outlook for the biotech sector... ► Artikel lesen | ||
19.08. | JDC Group - Gaining a firm foothold in commercial insurers | 358 | JDC Group's (JDC's) H124 results were strong, with organic revenue growth close to 20% and an EBITDA margin of 6.5% (H123: 6%). Management reiterated its FY24 guidance of €205-220m of revenue and €14.5-16m... ► Artikel lesen | ||
19.08. | VietNam Holding - Steady outperformance and solid fundamentals | 297 | VietNam Holding (VNH) posted a solid net asset value (NAV) per share total return (TR) in the first seven months of 2024 (7M24) of 14.5% in US dollar terms, which was ahead of the Vietnam All Share... ► Artikel lesen | ||
19.08. | Kolibri Global Energy - Longer laterals are a potential game changer | 267 | Kolibri Global Energy (KEI) reported Q224 results that saw double-digit increases across all financial and operating metrics on a y-o-y basis, with production and EBITDA up 37% and 40%, respectively.... ► Artikel lesen | ||
19.08. | Dowlais Group - Powder Metallurgy in the spotlight | 579 | Weaker global automotive production in 2024 is proving a challenge for Dowlais Group. Benefits from the restructuring programme and market recovery in 2025/26 should still see target double-digit margins... ► Artikel lesen | ||
16.08. | Dentsu Group - Positive momentum | 280 | Dentsu's H124 figures show sequential quarterly improvements, with the group posting organic growth of 0.2% in Q2. Encouragingly, this is in part ascribed to improved pitch win rates in all four reporting... ► Artikel lesen | ||
15.08. | Basilea Pharmaceutica - Poised for an eventful H224 | 330 | Basilea's H124 results reflect strong momentum across its pipeline and we expect the pace to accelerate in H224. The key highlight of the period was the FDA approval of Zevtera. We now expect all eyes... ► Artikel lesen | ||
14.08. | Immix Biopharma - Full steam ahead with US CAR-T trial | 290 | Immix Biopharma's second quarter was headlined by intensified clinical activity for lead CAR-T asset NXC-201 (targeting amyloid light chain amyloidosis, ALA), followed by commencement of patient dosing... ► Artikel lesen | ||
14.08. | BB Biotech - Lower rates and news flow to support recovery | 1.104 | BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech... ► Artikel lesen | ||
14.08. | Deutsche Beteiligungs - Doubling down on investment opportunities | 489 | Deutsche Beteiligungs (DBAG) reported a c 4% NAV total return in 9M24, supported primarily by higher valuation multiples on the back of more benign public markets and the successful realisation of in-tech.... ► Artikel lesen | ||
14.08. | Pan American Silver - Q224 results: Steady progress | 940 | Pan American Silver (PAAS) delivered a robust set of Q224 results, with lower silver production offset by the stronger sales and commodity prices. This was coupled with good cost control in the gold... ► Artikel lesen | ||
14.08. | Sylvania Platinum - Long-term PGM price upside | 486 | Sylvania's Q424 results were negatively affected by a delayed recovery in production following the 22-day strike during Q324. This resulted in 21% lower revenue than expected and EBITDA of only US$2.8m... ► Artikel lesen | ||
14.08. | BlackRock Greater Europe Investment Trust - High-quality fund in underappreciated region | 342 | BlackRock Greater Europe Investment Trust's (BRGE's) co-managers Stefan Gries and Alexandra Dangoor remain positive on the trust's prospects despite a mixed macroeconomic backdrop. Although the Chinese... ► Artikel lesen | ||
13.08. | Verve Group - Another substantial upgrade | 734 | Verve's AI-driven, privacy-first advertising solutions are gaining good traction and market share is increasing, with a 33% uplift in the number of larger software clients and 24% more ad impressions... ► Artikel lesen | ||
13.08. | CLIQ Digital - Sales decline decelerating in Q224 | 663 | CLIQ Digital's H124 results were as expected following the July trading update, at which point the company lowered its guidance. The change in the refund policies of credit card providers resulted in... ► Artikel lesen | ||
12.08. | S&U - Anticipating regulatory clarity in H2 | 223 | S&U's H1 trading statement revealed similar trends to those in Q1. Advantage Finance remains in a consolidation phase amid industry discussions with the FCA on collections procedures and forbearance.... ► Artikel lesen | ||
12.08. | Team Internet Group - Earnings remain resilient | 289 | Team Internet's H1 earnings showed resilience despite continued headwinds in online marketing. Going into the typically seasonally stronger H2, we expect the company's initiatives in product innovation... ► Artikel lesen | ||
09.08. | AFT Pharmaceuticals - Hikma partnership expands to include Combogesic | 300 | AFT Pharmaceuticals has expanded its licensing partnership with Hikma in the US to include distribution of the recently launched Combogesic tablets (Maxigesic Rapid). We view this as a logical step... ► Artikel lesen |